Interleukin-12 gene therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Interleukin-12 gene therapy, covering 2017-01-11 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer [Phase 2]